| abstract |
The present invention relates to a class of benzimidazole derivatives and their use in therapy. These compounds are known as TNF? are modulators of signal transduction and are thus useful as pharmaceutical agents in the treatment of particularly inflammatory and autoimmune disorders, neurological and neurodegenerative disorders, pain and nociceptive disorders, cardiovascular disorders, metabolic disorders, ocular disorders and oncologic disorders. |